Asston Pharmaceuticals IPO Will Open On July 09, 2025 And Close On July 11, 2025. The ₹27.56 Cr. IPO Is A Book Build Issue, Consisting Entirely Of A Fresh Issue.Asston Pharmaceuticals IPO Price Band Is Set At ₹ 115 to 123 Per Share.
The Allotment Will Be Finalized On July 14, 2025 and Listing date is Expected on The BSE SME By July 16, 2025. Investor Quota like 47.30% QIB, 33.29% Retail, and 14.37% HNI and Market maker Portion 5.04% Category.
Financial Year 2025 Company Posted a Revenue of ₹6.21 Cr. and A Net Profit of ₹1.32 Cr. Showing Strong Growth From The Previous Year. Based On Financial, The IPO Looks Promising For Long-term Investors.
About Asston Pharmaceuticals Limited
Our Company was originally incorporated on April 16, 2019 “Asston Pharmaceuticals Limited” Our Company is engaged in the manufacturing and export of both pharmaceutical formulations and nutraceutical products in domestic and various African markets.
Our Company operates under brand “Asston”. Presently, our Company is involved in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel and Lotion) and Oral Powder (Sachet, Dry Syrup) etc.
Apart from manufacturing products for direct sales, our Company also manufactures various pharmaceutical products for different marketers on loan license or on contract manufacturing basis. Our business is primarily conducted on a principle-to-principle basis with various marketers.
Asston Pharmaceuticals IPO Dates & Price Band Details
| IPO Open Date | July 09, 2025 |
|---|---|
| IPO Close Date | July 11, 2025 |
| IPO Price Band | ₹ 115 to 123 per share |
| Face Value | ₹10 per equity share |
| Lot Size | 1,000 Shares |
| Minimum Investment | ₹1,23,000 Lakhs (for 1 lot at ₹123) |
| IPO Issue Type | Bookbuilding IPO |
| Total Issue Size | 22,41,000 shares (Approx ₹ 27.56 Cr) |
| Fresh Issue | 22,41,000 shares (Approx ₹ 27.56 Cr) |
| Offer for Sale | - |
| Retail Investor Quota | 33.29% |
| QIB Quota | 47.30% |
| Market Maker Shares | 5.04% |
| NII (HNI) Quota | 14.37% |
| Listing Exchange | BSE SME |
| Anchor Investor List | Click Here |
| DRHP (Draft Prospectus) | Click Here |
| RHP (Final Prospectus) | Click Here |
Asston Pharmaceuticals IPO Market Lot Size
The Minimum Lot Size For The Asston Pharmaceuticals IPO is 2,000 Shares, Requiring An Application Amount of ₹1,23,000 and in multiples of 2,000 For Retail Investors. Investors Must Apply in Multiples of The Lot Size.
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 1,000 | ₹1,23,000 |
| Retail Maximum | 1 | 1,000 | ₹1,23,000 |
| S-HNI Minimum | 2 | 2,000 | ₹2,46,000 |
Objects Of The Issue
1. Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit.
2. Funding the incremental working capital requirements of our Company.
3. Repayment and/or prepayment, in part or full, of certain of our outstanding borrowings availed by our Company.
4. General Corporate Purposes.
Asston Pharmaceuticals IPO Allotment & Listing Dates
Asston Pharmaceuticals IPO Will Open on July 09 and Close on July 11, 2025. The allotment is Expected on July 14, With the Listing Scheduled on BSE SME For July 16, 2025 (More information below table).
| Anchor Investor Bidding | Jul 08, 2025 |
|---|---|
| IPO Open | Jul 09, 2025 |
| IPO Close | Jul 11, 2025 |
| Allotment Finalisation | Jul 14, 2025 |
| Refunds / Unblocking | Jul 15, 2025 |
| Shares Credited to Demat | Jul 15, 2025 |
| Listing Date | Jul 16, 2025 |
Asston Pharmaceuticals IPO Financial Report (FY 2025)
Asston Pharmaceuticals Reported a total Revenue of ₹6.21 Cr. in FY 2025, Slightly up From ₹15.84 Cr. in FY 2024. The Company Net Profit Also Rose to ₹1.32 Cr. From ₹1.36 Cr. in the Previous Year Showing Consistent Financial Growth Ahead of its IPO. (More information below table).
| Period Ended | 31 May 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 31.83 | 28.12 | 20.26 | 13.69 |
| Revenue | 6.21 | 25.61 | 15.84 | 7.19 |
| Profit After Tax | 1.32 | 4.33 | 1.36 | 1.06 |
| EBITDA | 1.93 | 6.16 | 2.55 | 1.52 |
| Net Worth | 12.04 | 10.72 | 6.39 | 1.99 |
| Reserves and Surplus | 5.77 | 4.45 | 5.61 | 1.29 |
| Total Borrowing | 7.83 | 7.26 | 6.82 | 5.25 |
| Amount in ₹ Crore |
Asston Pharmaceuticals IPO Valuation Report – FY 2025 (KPI)
Check DetailedAsston Pharmaceuticals IPO Valuation Metrics for FY 2025, including EPS, P/E Ratio, RoNW, NAV, ROCE, and other key financial indicators. These Ratios help Investors Assess the Company financial Health & Valuation Before applying for The IPO. (More information below table).
| KPI | Value |
|---|---|
| Return on Equity (ROE) | 50.56% |
| Return on Capital Employed (ROCE) | 51.25% |
| EBITDA Margin | 24.460% |
| PAT Margin | 17.27% |
| Debt-to-Equity Ratio | 0.68 |
| Earnings Per Share (EPS) | 6.90 |
| Price to Earnings Ratio (P/E) | 17.82 |
| Return on Net Worth (RoNW) | 40.36% |
| Net Asset Value (NAV) | 17.09 |
Qualitative Factors
- Formulation Expertise.
- Experienced Promoters.
- Wide range of Products.
- Strategic Location.
- Skilled Workforce
- Good relationship with contract manufacturers
- Quality Assurance
- Good relationship with clients in the export market
- Competitive Pricing
- Asset Light Model
Our Company Promoters
- Dr. Ashish Narayan Sakalkar,
- Saili Jayaram More
- Sachin Chandrakant Badakh
Comparison of Accounting Ratios with Industry Peers
| Name of the company | Face Value (Per share) | EPS (Rs) | P/E Ratio | RONW (%) | NAV (Rs. Per share) | Revenue from Operations (₹in Lakhs) |
|---|---|---|---|---|---|---|
| Asston Pharmaceuticals Limited | 10.00 | 6.90 | 17.82 | 40.36% | 17.09 | Standalone |
| Shelter Pharma Limited | 10.00 | 6.26 | 6.70 | 16.94% | 36.96 | Standalone |
| Bafna Pharmaceuticals Limited | 10.00 | 1.76 | 51.38 | 4.89% | 35.86 | Standalone |
| Trident Lifeline Limited | 10.00 | 11.35 | 25.29 | 19.85% | 57.16 | Standalone |
Also Read – Asston Pharmaceuticals IPO GMP Today, Grey Market Premium Live
Asston Pharmaceuticals Company Contact Details
Registered Office: 4th Floor, Office No A-431,
Balaji Bhavan, Plot No 42A Sector-11, CBD Belapur,
Navi Mumbai, Thane – 400 614, Maharashtra, India
Tel. No: +91 22 49731411/+91 2249731419
E-mail: info@asstonpharmaceuticals.com
Website: www.asstonpharmaceuticals.com
Asston Pharmaceuticals Lead Manager
SOBHAGYA CAPITAL OPTIONS PRIVATE LIMITED
C-7 to C-7A, Gate No-01, Hosiery Complex,
Phase-II Extension, Noida-201305
Tel. No.: +91 7836066001
Email: cs@sobhagyacap.com
Website: www.sobhagyacapital.com
Asston Pharmaceuticals IPO Registrar
MAASHITLA SECURITIES PRIVATE LIMITED
451, Krishna Apra Business Square,
Netaji Subhash Place, Pitampura, Delhi- 110 034
Tel. Number: +91 11 47581432
Email: ipo@maashitla.com
Website: www.maashitla.com
Asston Pharmaceuticals IPO FAQs
Question 1: What is the Asston Pharmaceuticals IPO?
Answer 1:Asston Pharmaceuticals IPO is a SME IPO of equity shares of the face value of ₹10 approximately up to ₹ 27.56 Cr. The issue is priced at 115 to 123 per share.
The Asston Pharmaceuticals IPO opens on 09, July 2025 and closes on 11, July 2025.
MAASHITLA SECURITIES PRIVATE LIMITED is the registrar for the IPO. The shares to be listed on NSE SME.
Question 2: How to apply inAsston Pharmaceuticals IPO through Groww?
Answer 2: Groww customers can apply online in Asston Pharmaceuticals IPO using UPI as a payment gateway. Groww customers can apply in Asston Pharmaceuticals IPO by login into Groww (back office) and submitting an IPO application form.
Steps to apply in Asston Pharmaceuticals IPO through Groww –
- Visit the Groww website and login to Groww.
- Go to Main Page and click the Products & tools and click IPO tab.
- New page Open and Show ‘AJC Jewel IPO’ click the ‘Apply’ button.
- Show IPO detail Shares lot Size and Bid Price & click here to Cutoff Price check Box and Continue.
- Inter Your UPI id like . 95****299@kotak accept terms and condition click Box and Apply For IPO
- groww share payment link Your UPI Mobile Number Pay Payment for IPO Bid to approve the e-mandate successfully submit application .
Question 3: When Asston Pharmaceuticals IPO will open?
Answer 3: The Asston Pharmaceuticals IPO opens on 9 July 25, 2025 and closes on July 11, 2025.
Question 4: What is the lot size of Asston Pharmaceuticals IPO?
Answer 4:Asston Pharmaceuticals IPO lot size and the minimum order quantity is 1,000 Shares.
Question 5: How to apply for Asston Pharmaceuticals IPO?
Answer 5: You can apply in Asston Pharmaceuticals IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don’t offer banking services. Read more detail about applying IPO online through Groww, Zerodha, Upstox, 5Paisa, Phonepe Share Market, HDFC Bank, and Angel one.
Question 6: When is Asston Pharmaceuticals IPO allotment date?
Answer 6: The Basis of Allotment for Asston Pharmaceuticals IPO will be on Monday, July 14, 2025, and the allotted shares will be credited to your demat account by Tuesday, July 15, 2025. For Check the Asston Pharmaceuticals IPO allotment status.
Question 7: When is Asston Pharmaceuticals IPO listing date?
Answer 7: The Asston Pharmaceuticals IPO listing date is 16, Jul 2025. The date of Asston Pharmaceuticals IPO listing on Wed, 16 Jul, 2025.
1 thought on “Asston Pharmaceuticals IPO 2025, Date, GMP, Price, Allotment, Review & Listing”